Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

43
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
43
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

38
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

54
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
54
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lead-Related and Procedural Outcomes of His Bundle Pacing Versus Left Bundle Branch Area Pacing in Patients Undergoing Atrioventricular Node Ablation: A Systematic Review and Meta-Analysis.

Journal of arrhythmia·2026
Same author

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
Same author

Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-Analysis of Randomized Controlled Trials.

The Canadian journal of cardiology·2026
Same author

GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Across Myocardial Infarction-Defined Populations: A Systematic Review and Meta-Analysis.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
Same author

Feasibility Study of Balloon Angioplasty for the Treatment of Ophthalmic Artery Stenoses in Patients With Geographic Atrophy.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Prognostic value of AI-enabled quantitative coronary CT angiography for major adverse cardiovascular events: A systematic review and meta-analysis.

International journal of cardiology. Cardiovascular risk and prevention·2026

相关实验视频

Updated: Sep 10, 2025

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.2K

查加斯病患者心力衰竭的临床和流行病学概况:来自SEPE-HF注册表的见解

Juliana Giorgi1, Roberto Cristodulo2, Carlos Vaca2

  • 1Hospital Sirio Libanes, São Paulo, São Paulo, Brazil; Hospital Albert Einstein, São Paulo, São Paulo, Brazil.

The American journal of cardiology
|August 20, 2025
PubMed
概括

查加斯心肌病 (Ch-CMP) 具有独特的心力衰竭特征,包括独特的心电图发现和较低的传统风险因素. 然而,Ch-CMP患者在出院时表现不佳,这突显了急需进行干预的情况.

关键词:
查加斯心肌病查加斯病心血管疾病死亡率心脏衰竭心脏衰竭与减少的喷射分数

更多相关视频

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

14.1K
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.4K

相关实验视频

Last Updated: Sep 10, 2025

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.2K
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

14.1K
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.4K

科学领域:

  • 心脏病学
  • 传染性疾病
  • 公共卫生

背景情况:

  • 查加斯心肌病 (Ch-CMP) 是一种特有的心力衰竭 (HF) 现型,与非查加斯HF不同.
  • 了解Ch-CMP独特的临床,心电图和治疗特征对于有效的治疗至关重要.
  • 由于疾病的特点,在查加斯流行地区对HF的管理需要特别考虑.

研究的目的:

  • 为了比较Chagas心肌病 (Ch- CMP) 与非Chagas心力衰竭 (HF) 的患者的临床特征,并发症和住院结局.
  • 在Ch-CMP中评估特定心电学异常和缩功能障碍的流行率.
  • 评估与非Chagas HF患者相比,Ch- CMP患者在出院时使用指导医疗疗 (GDMT).

主要方法:

  • 在巴西的第三级中心对417名因失补偿性肺炎住院的患者进行了回顾性队列研究.
  • 患者被分为确诊的查加斯心肌病 (Ch- CMP) 和非查加斯心肌病组.
  • 收集的数据包括人口统计,并发症,心电图发现,左心室喷射率 (LVEF),住院死亡率和出院药物.

主要成果:

  • 查加斯患者 (37. 1%) 比非查加斯HF患者年轻,BMI较低,并较少出现并发症 (高血压,缺血性心脏病).
  • 在Ch- CMP患者中,右束支部阻塞,心房动,心脏起器节奏和静脉功能障碍的发病率较高 (LVEF < 40%).
  • 住院死亡率相似,但GDMT使用 (β- 阻断剂,ACEi/ ARB/ ARNi) 在Ch- CMP患者出院时显著降低.

结论:

  • 查加斯心肌病是HF住院的重要原因,其特点是心律失常和较少的传统风险因素.
  • 尽管死亡率相似,但Ch- CMP患者在出院时在GDMT中面临显著的治疗差距,需要有针对性的干预措施.
  • 由于C-CMP的独特特征,需要专门的管理策略来改善长期结果并解决治疗差异.